Blog

Novartis buys another 2.5 percent in Israel's Gamida Cell

Swiss drugmaker Novartis will invest up to an extra $15 million in Gamida Cell, an Israeli developer of stem cell therapies, Gamida said on Sunday. Novartis last year invested $35 million in the company for a 15 percent stake, in a deal that could reach $600 million if Novartis exercises a buyout option that expires in 2016. The $15 million investment will be used to advance Gamida Cell’s clinical programs,

Florida circus elephants find second career in research

At a Florida retirement home for former circus elephants, residents enjoy a steady diet of high-quality hay and local fruits and vegetables, as well as baths and occasional walks. For these majestic beasts, this life of relative leisure at the 200-acre Center for Elephant Conservation comes after years on the road, entertaining America in “The Greatest Show on Earth” for Ringling Bros and Barnum & Bailey Circus. In March, the circus

California adopts tough rules for antibiotic use in farm animals

By Lisa Baertlein LOS ANGELES (Reuters) – California Governor Jerry Brown on Saturday signed a bill that sets the strictest government standards in the United States for the use of antibiotics in livestock production. The move from California, known for its leadership on public health and environmental issues, comes amid growing concern that the overuse of such drugs is contributing to rising numbers of life-threatening human infections from antibiotic-resistant bacteria

U.S. to make payments to families of Kunduz air strike victims: Pentagon

The U.S. Department of Defense will seek to make “condolence payments” to families of victims of a U.S. air strike that mistakenly hit a Medecins Sans Frontieres hospital in Kunduz, Afghanistan, killing 22 people, the Pentagon said on Saturday. “The Department of Defense believes it is important to address the consequences of the tragic incident at the Doctors Without Borders hospital in Kunduz, Afghanistan,” spokesman Peter Cook said in a